201 related articles for article (PubMed ID: 17692017)
1. Rho-ROCK inhibitors as emerging strategies to promote nerve regeneration.
Kubo T; Hata K; Yamaguchi A; Yamashita T
Curr Pharm Des; 2007; 13(24):2493-9. PubMed ID: 17692017
[TBL] [Abstract][Full Text] [Related]
2. Rho-ROCK inhibitors for the treatment of CNS injury.
Kubo T; Yamashita T
Recent Pat CNS Drug Discov; 2007 Nov; 2(3):173-9. PubMed ID: 18221230
[TBL] [Abstract][Full Text] [Related]
3. The therapeutic effects of Rho-ROCK inhibitors on CNS disorders.
Kubo T; Yamaguchi A; Iwata N; Yamashita T
Ther Clin Risk Manag; 2008 Jun; 4(3):605-15. PubMed ID: 18827856
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Rho kinase (ROCK) increases neurite outgrowth on chondroitin sulphate proteoglycan in vitro and axonal regeneration in the adult optic nerve in vivo.
Lingor P; Teusch N; Schwarz K; Mueller R; Mack H; Bähr M; Mueller BK
J Neurochem; 2007 Oct; 103(1):181-9. PubMed ID: 17608642
[TBL] [Abstract][Full Text] [Related]
5. Cytoplasmic p21(Cip1/WAF1) enhances axonal regeneration and functional recovery after spinal cord injury in rats.
Tanaka H; Yamashita T; Yachi K; Fujiwara T; Yoshikawa H; Tohyama M
Neuroscience; 2004; 127(1):155-64. PubMed ID: 15219678
[TBL] [Abstract][Full Text] [Related]
6. Axon growth inhibition by RhoA/ROCK in the central nervous system.
Fujita Y; Yamashita T
Front Neurosci; 2014; 8():338. PubMed ID: 25374504
[TBL] [Abstract][Full Text] [Related]
7. Rho kinase inhibition enhances axonal regeneration in the injured CNS.
Fournier AE; Takizawa BT; Strittmatter SM
J Neurosci; 2003 Feb; 23(4):1416-23. PubMed ID: 12598630
[TBL] [Abstract][Full Text] [Related]
8. Rho/ROCK pathway and neural regeneration: a potential therapeutic target for central nervous system and optic nerve damage.
Tan HB; Zhong YS; Cheng Y; Shen X
Int J Ophthalmol; 2011; 4(6):652-7. PubMed ID: 22553739
[TBL] [Abstract][Full Text] [Related]
9. Delayed treatment with Rho-kinase inhibitor does not enhance axonal regeneration or functional recovery after spinal cord injury in rats.
Nishio Y; Koda M; Kitajo K; Seto M; Hata K; Taniguchi J; Moriya H; Fujitani M; Kubo T; Yamashita T
Exp Neurol; 2006 Aug; 200(2):392-7. PubMed ID: 16624299
[TBL] [Abstract][Full Text] [Related]
10. Strategies to neutralize RhoA/ROCK pathway after spinal cord injury.
Roy A; Pathak Z; Kumar H
Exp Neurol; 2021 Sep; 343():113794. PubMed ID: 34166685
[TBL] [Abstract][Full Text] [Related]
11. Axonal growth inhibitors and their receptors in spinal cord injury: from biology to clinical translation.
Chambel SS; Cruz CD
Neural Regen Res; 2023 Dec; 18(12):2573-2581. PubMed ID: 37449592
[TBL] [Abstract][Full Text] [Related]
12. PirB is a novel potential therapeutic target for enhancing axonal regeneration and synaptic plasticity following CNS injury in mammals.
Gou Z; Mi Y; Jiang F; Deng B; Yang J; Gou X
J Drug Target; 2014 Jun; 22(5):365-71. PubMed ID: 24405091
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of the Rho-ROCK signaling pathway to promote neurologic recovery after spinal cord injuries in rats.
Wu BQ; Bi ZG; Qi Q
Chin Med J (Engl); 2013; 126(19):3723-7. PubMed ID: 24112171
[TBL] [Abstract][Full Text] [Related]
14. Neuronal responses to myelin are mediated by rho kinase.
Alabed YZ; Grados-Munro E; Ferraro GB; Hsieh SH; Fournier AE
J Neurochem; 2006 Mar; 96(6):1616-25. PubMed ID: 16441511
[TBL] [Abstract][Full Text] [Related]
15. Suppression of Rho-kinase activity promotes axonal growth on inhibitory CNS substrates.
Borisoff JF; Chan CC; Hiebert GW; Oschipok L; Robertson GS; Zamboni R; Steeves JD; Tetzlaff W
Mol Cell Neurosci; 2003 Mar; 22(3):405-16. PubMed ID: 12691741
[TBL] [Abstract][Full Text] [Related]
16. [Molecular mechanism and regulation of axon growth inhibition].
Yamashita T
Brain Nerve; 2007 Dec; 59(12):1347-53. PubMed ID: 18095484
[TBL] [Abstract][Full Text] [Related]
17. Rho signaling pathway targeted to promote spinal cord repair.
Dergham P; Ellezam B; Essagian C; Avedissian H; Lubell WD; McKerracher L
J Neurosci; 2002 Aug; 22(15):6570-7. PubMed ID: 12151536
[TBL] [Abstract][Full Text] [Related]
18. Dose-dependent beneficial and detrimental effects of ROCK inhibitor Y27632 on axonal sprouting and functional recovery after rat spinal cord injury.
Chan CC; Khodarahmi K; Liu J; Sutherland D; Oschipok LW; Steeves JD; Tetzlaff W
Exp Neurol; 2005 Dec; 196(2):352-64. PubMed ID: 16154567
[TBL] [Abstract][Full Text] [Related]
19. A novel ROCK inhibitor, Y-39983, promotes regeneration of crushed axons of retinal ganglion cells into the optic nerve of adult cats.
Sagawa H; Terasaki H; Nakamura M; Ichikawa M; Yata T; Tokita Y; Watanabe M
Exp Neurol; 2007 May; 205(1):230-40. PubMed ID: 17359977
[TBL] [Abstract][Full Text] [Related]
20. Small-molecule-induced Rho-inhibition: NSAIDs after spinal cord injury.
Kopp MA; Liebscher T; Niedeggen A; Laufer S; Brommer B; Jungehulsing GJ; Strittmatter SM; Dirnagl U; Schwab JM
Cell Tissue Res; 2012 Jul; 349(1):119-32. PubMed ID: 22350947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
